Skip to search formSkip to main contentSkip to account menu

abediterol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Results of three Phase II trials with the long-acting β2-adrenergic agonist (LABA) abediterol in patients with persistent asthma
2014
2014
Abediterol, a novel long-acting inhaled β2-agonist, has a fast association rate and long residence time at human β2 receptors
Background Abediterol (LAS100977) is a novel, long-acting, inhaled β 2 -receptor agonist (LABA) in Phase II development for… 
2014
2014
Pharmacokinetics (PK), safety and tolerability of abediterol and mometasone furoate fixed- and free-dose combinations in healthy subjects
Background Abediterol (LAS100977) is a novel, once-daily, LABA in development for the treatment of asthma and COPD. We… 
2014
2014
Abediterol: Efficacy, safety and tolerability of the novel LABA in patients with persistent asthma
Background: Abediterol (LAS100977) is a novel, once-daily, LABA in development for treatment of asthma and COPD. Previously…